Journal of Cardiovascular Disease Research
DYSLIPIDEMIA IN CHRONIC RENAL FAILURE ASSOCIATED CARDIOVASCULAR DISEASE :A HOSPITAL BASED STUDY
Dr. Sachin G J, Dr. Varun K, Dr. Rajiv Konin, Dr. Shilpa Bhimalli
JCDR. 2023: 1515-1524
Abstract
Lipid disorders are one of the known metabolic changes associated with chronic renal failure (CRF) The prominent features of uremic dyslipidemia are an increase in plasma triglycerides and cholesterol in nearly all lipoproteins, and a reduction in high-density lipoprotein (HDL) cholesterol. Cardiovascular disease (CVD) is a major cause of mortality in patients with chronic renal failure (CRF). One of the risk factors for cardiovascular disease is dyslipidemia as it accelerates atherosclerosis. Therefore it is essential to study uremic dyslipidemia, since optimal treatment is essential for the prevention or delay of cardiovascular complications in patients with CRF.
» PDF